Skip to Main Content

Paper Details

Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
Cancer Genet
18
2018
Author NameAffiliation
Xinjie XuUniversity of Utah School of Medicine
Rashmi Kanagal-ShamannaThe University of Texas M.D. Anderson Cancer Center
Gordana RacaChildren's Hospital of Los Angeles
  • 1 - 3

Datasets

Release 1.2